Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Hazel Hunt | Chief Scientific Officer | 2025-02-11 | 150,000 | $3.29 | $493.50kBuy |
Hazel Hunt | Chief Scientific Officer | 2025-02-11 | 85,176 | $68.11 | $5.80MSell |
Daniel N. Swisher Jr. | Director | 2025-02-10 | 2,200 | $12.13 | $26.69kBuy |
Daniel N. Swisher Jr. | Director | 2025-02-10 | 2,200 | $68.08 | $149.78kSell |
Joseph Douglas Lyon | Chief Accounting Technology Officer | 2025-02-03 | 1,571 | $11.35 | $17.83kBuy |
Joseph Douglas Lyon | Chief Accounting Technology Officer | 2025-02-03 | 3,429 | $13.56 | $46.50kBuy |
Sean Maduck | Officer | 2025-02-03 | 11,986 | $3.88 | $46.51kBuy |
Joseph Douglas Lyon | Chief Accounting Technology Officer | 2025-02-03 | 5,000 | $66.92 | $334.60kSell |
Sean Maduck | Officer | 2025-02-03 | 20,000 | $66.92 | $1.34MSell |
Sean Maduck | Officer | 2025-02-03 | 8,014 | $5.05 | $40.47kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Patrick G. Enright | 42.76% | 44,802,403 | $3.26B | Insider |
Blackrock Inc | 14.96% | 15,677,327 | $1.14B | Institution |
Bakker Juliet Tammenoms | 10.58% | 11,089,541 | $806.43M | Insider |
Longitude Venture Partners LP | 10.46% | 10,956,002 | $796.72M | Insider |
Vanguard Group Inc | 9.65% | 10,115,624 | $735.61M | Institution |
Alta Biopharma Partners II LP | 9.53% | 9,982,720 | $725.94M | Insider |
G. Leonard Baker Jr. | 8.78% | 9,200,067 | $669.03M | Insider |
Ingalls Snyder LLC | 7.73% | 8,099,747 | $589.01M | Institution |
Tench Coxe | 6.58% | 6,890,503 | $501.08M | Insider |
Joseph C. Cook Jr. | 6.46% | 6,765,805 | $492.01M | Insider |